Full-Time

Lead Engineer

Systems Engineering, Salesforce Architect

Updated on 8/23/2026

Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

No salary listed

Pune, Maharashtra, India

In Person

Bachelor's, Master's

Category
Software Engineering (1)
Required Skills
Microsoft Azure
Agile
Red Hat
Version Control
Salesforce
AWS
JIRA
Observability
DevOps

Get referred to Cencora

See people who can refer or advise you

Requirements
  • A bachelor's degree in Computer Science, Information Technology, Engineering, or a related field, or equivalent professional experience.
  • Eight or more years of enterprise technology experience, including significant experience delivering solutions on the Salesforce platform.
  • Demonstrated experience performing solution or delivery architecture responsibilities within complex enterprise programs.
  • Strong understanding of Salesforce solution design, configuration, custom development, integration, data, security, and application lifecycle considerations.
  • Experience translating high-level architecture into executable technical work packages and delivery backlogs.
  • Ability to make pragmatic technical decisions while maintaining alignment with long-term architecture.
  • Experience working in Agile delivery environments and with tools such as Jira.
  • Strong analytical, problem-solving, documentation, and communication skills.
  • Ability to collaborate effectively across global, cross-functional teams.
  • A bachelor's degree in Computer Science, Software Engineering, Computer Engineering, Information Systems, or a related field, or equivalent experience.
  • Six or more years of experience in software engineering, systems engineering, application development, platform engineering, or a related field.
  • Knowledge of advanced software and systems engineering principles, development lifecycle practices, testing strategies, and production support models.
  • Knowledge of application architecture, system design, integration patterns, cloud and infrastructure components, and secure engineering practices.
  • Knowledge of performance engineering, scalability, reliability, resilience, observability, and operational support frameworks.
  • Skill in technical design, coding or configuration, debugging, root cause analysis, performance tuning, and structured problem solving.
  • Skill in using development frameworks, testing tools, source control platforms, continuous integration and continuous delivery pipelines, observability tools, collaboration platforms, and work management systems.
  • Ability to lead complex engineering work independently while applying strong technical judgment, quality standards, and risk awareness.
  • Ability to influence technical direction, guide design decisions, and collaborate effectively with technical and non-technical stakeholders.
  • Ability to mentor less experienced engineers and drive adoption of engineering best practices, documentation standards, and continuous improvement methods.
Responsibilities
  • Translate domain strategy, target architecture, standards, and guardrails established by the Principal Architect into project-level solution architecture.
  • Lead solution design for initiatives delivered by the assigned delivery team, including architecture diagrams, technical approaches, integration considerations, data considerations, security requirements, and non-functional requirements.
  • Decompose large architecture solutions into sequenced, workable technical deliverables with clear boundaries, dependencies, implementation approaches, and ownership.
  • Work with Product Owners, Business Analysts, Engineering Leads, and Technical Leads to translate architecture into Jira epics, technical enablers, stories, and implementation milestones.
  • Determine the appropriate size, sequence, and working order of technical deliverables so Technical Leads can take ownership of clearly defined implementation work.
  • Maintain architecture involvement throughout implementation and close gaps between approved solution designs and the realities discovered during delivery.
  • Guide in-flight technical decisions, including configuration versus custom development, low-code versus pro-code approaches, integration patterns, data design, security design, and other implementation-level choices.
  • Review detailed designs and implementation outcomes to ensure alignment with architectural intent and approved standards.
  • Document significant architecture decisions, assumptions, dependencies, risks, and deviations.
  • Identify architecture risks, technical debt, cross-team dependencies, and non-functional concerns early in the delivery lifecycle.
  • Recommend remediation when implementations deviate from approved architecture or create unacceptable platform risk.
  • Escalate cross-domain decisions, material exceptions, and enterprise-level concerns to the Principal Architect or appropriate architecture governance forum.
  • Provide architecture guidance and coaching to Technical Leads, developers, and other delivery team members.
  • Contribute reusable patterns, lessons learned, and delivery feedback to the Salesforce architecture community and Center of Excellence.
Desired Qualifications
  • Salesforce architect-level or advanced technical certifications.
  • Experience supporting large-scale, multi-team Salesforce environments.
  • Experience operating within formal architecture governance and design-review processes.
  • Experience working in regulated, highly integrated, or globally distributed enterprise environments.
  • A master's degree in Computer Science, Software Engineering, Computer Engineering, Information Systems, or a related field, or equivalent experience.
  • AWS Certified Cloud Practitioner (CLF-C02), Azure Fundamentals (AZ-900), Red Hat Certified System Administrator certification, or equivalent.

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Get referred to Cencora

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026: Cencora raised fiscal 2026 EPS guidance to $17.75-$17.95.
  • July 31, 2026: Cencora expanded its revolver to $7 billion, extending maturity to 2031.
  • Cencora completed $1 billion in share repurchases during Q3, reducing diluted shares to 194 million.

What critics are saying

  • Baltimore dropped its opioid case after Maryland's April 2026 ruling vacated Cencora's $152 million verdict.
  • Cencora directors still face a $111.3 million opioid settlement, confirming persistent litigation over legacy conduct.
  • A California labor class action and heavy debt coverage pressure threaten margins before fiscal 2027.

What makes Cencora unique

  • Cencora's specialty platform, including OneOncology and RCA MSOs, drives outsized growth on August 5, 2026.
  • Nucleus inventory tools embed Cencora inside specialty physician practices' workflows across 20+ sites.
  • Global distribution plus World Courier and European 3PL give Cencora reach beyond U.S. drug flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Company News

Yahoo Finance
Aug 14th, 2026
Cencora beats Q2 profit estimates as specialty pharma platform drives growth

Cencora reported second-quarter revenue of $84.75 billion, slightly above analyst estimates of $84.43 billion, representing 5.1% year-on-year growth. Adjusted earnings per share came in at $4.48, beating consensus estimates of $4.35 by 3%. Management attributed the performance to strength in specialty pharmaceuticals, particularly through Management Services Organisations like OneOncology and RCA. CEO Robert Mauch highlighted the company's positioning in specialty care, stating, "Our specialty platform supports growth across the healthcare ecosystem." The company raised its full-year adjusted EPS guidance to $17.85 at the midpoint. Operating margin held steady at 1.3%, matching the same quarter last year. During the earnings call, analysts questioned management about biosimilar opportunities, specialty logistics competition, and potential policy risks from proposed ASP rule changes.

Yahoo Finance
Aug 12th, 2026
Cencora raises FY2026 guidance after Q3 EPS jumps 12%, buys back $1B in shares

Cencora reported strong third-quarter results for fiscal year 2026, driven by execution across its business units and investments in its specialty positioning. The pharmaceutical distributor achieved double-digit adjusted operating income growth and 12% earnings per share growth in the quarter. The company conducted $1 billion in opportunistic share repurchases during the period. Based on its performance and confidence in continued execution, Cencora raised its fiscal 2026 EPS guidance. President and CEO Robert Mauch credited the results to the company's team members and their commitment to providing solutions for customers. He highlighted the strength of Cencora's portfolio and its pharmaceutical-centric strategy as the company approaches the end of its fiscal year. The earnings call was held on 5 August 2026, with senior leadership including Mauch and CFO Eva Boratto participating.

MarketScreener
Aug 5th, 2026
Cencora boosts credit facility to $7B, extends maturity to 2031

Cencora and its subsidiary Innomar Strategies have amended their credit agreement, increasing their multi-currency revolving credit facility from $5.5 billion to $7.0 billion. The facility's maturity date has been extended to July 2031. Interest rates on borrowings range from 69.5 to 110 basis points over various term rates, depending on Cencora's public debt ratings. The agreement includes covenants such as a maximum financial leverage ratio. Separately, on 31 July 2026, Cencora amended its receivables securitisation facility, reducing it from $1.5 billion to $1.0 billion whilst increasing the accordion feature from $500 million to $1.0 billion. This gives the company the option to expand commitments by up to $1.0 billion, subject to bank approval.

Yahoo Finance
Aug 1st, 2026
Cencora Q3 earnings preview: analysts expect $4.37 EPS on $84.89B revenue

Wall Street analysts expect Cencora to report quarterly earnings of $4.37 per share, marking a 9.3% year-over-year increase. Revenues are projected to reach $84.89 billion, up 5.2% from the same quarter last year. Over the past 30 days, the consensus earnings per share estimate has been revised upward by 1.3%. Analysts forecast revenue from Total US Healthcare Solutions at $75 billion, representing 2.9% year-over-year growth. International Healthcare Solutions revenue is expected to remain flat at $7.79 billion. Operating income projections show US Healthcare Solutions at $940.87 million and International Healthcare Solutions at $158.45 million. Cencora shares have risen 5.3% over the past month and hold a Zacks Rank of 2, indicating expected outperformance versus the broader market.

Yahoo Finance
Jul 13th, 2026
CVS Health leads Q1 health insurance earnings as Cencora misses revenue estimates by 3.9%

CVS Health led health insurance providers in Q1, with revenues of $100.4 billion, up 6.2% year on year and beating analyst expectations by 6.3%. The company exceeded full-year EPS guidance estimates. The 12 health insurance provider stocks tracked reported strong Q1 results overall. Revenues beat consensus estimates by 1.4%, whilst next quarter's guidance was in line. Share prices rose 37.4% on average following the earnings announcements. Cencora performed weakest amongst peers, reporting revenues of $78.36 billion, up 3.8% year on year. This fell short of analyst expectations by 3.9%. The stock has remained flat since reporting and currently trades at $303.53. The industry faces tailwinds from an ageing population and improved data analytics, but regulatory scrutiny on pricing and medical cost inflation may impact margins.